Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

342 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparative effectiveness of antitumour necrosis factor agents, biologics with an alternative mode of action and tofacitinib in an observational cohort of patients with rheumatoid arthritis in Switzerland.
Finckh A, Tellenbach C, Herzog L, Scherer A, Moeller B, Ciurea A, von Muehlenen I, Gabay C, Kyburz D, Brulhart L, Müller R, Hasler P, Zufferey P; physicians and patients of the SCQM. Finckh A, et al. Among authors: gabay c. RMD Open. 2020 May;6(1):e001174. doi: 10.1136/rmdopen-2020-001174. RMD Open. 2020. PMID: 32385143 Free PMC article.
Rituximab in the treatment of antisynthetase syndrome.
Brulhart L, Waldburger JM, Gabay C. Brulhart L, et al. Among authors: gabay c. Ann Rheum Dis. 2006 Jul;65(7):974-5. doi: 10.1136/ard.2005.045898. Ann Rheum Dis. 2006. PMID: 16769789 Free PMC article. No abstract available.
Cigarette smoking and radiographic progression in rheumatoid arthritis.
Finckh A, Dehler S, Costenbader KH, Gabay C; Swiss Clinical Quality Management project for RA. Finckh A, et al. Among authors: gabay c. Ann Rheum Dis. 2007 Aug;66(8):1066-71. doi: 10.1136/ard.2006.065060. Epub 2007 Jan 19. Ann Rheum Dis. 2007. PMID: 17237117 Free PMC article.
B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents.
Finckh A, Ciurea A, Brulhart L, Kyburz D, Möller B, Dehler S, Revaz S, Dudler J, Gabay C; Physicians of the Swiss Clinical Quality Management Program for Rheumatoid Arthritis. Finckh A, et al. Among authors: gabay c. Arthritis Rheum. 2007 May;56(5):1417-23. doi: 10.1002/art.22520. Arthritis Rheum. 2007. PMID: 17469098 Free article.
Tolerance and effectiveness of anti-tumor necrosis factor alpha therapies in elderly patients with rheumatoid arthritis: a population-based cohort study.
Genevay S, Finckh A, Ciurea A, Chamot AM, Kyburz D, Gabay C; Physicians of the Swiss Clinical Quality Management Program for Rheumatoid Arthritis. Genevay S, et al. Among authors: gabay c. Arthritis Rheum. 2007 May 15;57(4):679-85. doi: 10.1002/art.22688. Arthritis Rheum. 2007. PMID: 17471545 Free article.
342 results